Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

9.50
Delayed Data
As of Jan 20
 +0.18 / +1.93%
Today’s Change
6.10
Today|||52-Week Range
13.80
+12.83%
Year-to-Date

Today’s Trading

Previous close9.32
Today’s open9.35
Day’s range9.19 - 9.67
Volume71,854
Average volume (3 months)53,913
Market cap$176.0M
Dividend yield41.24%
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-450.00%
Earnings growth (this year)-65.91%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.71

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.10+1.09%
CTSOCytosorbents Corp+0.10+1.71%
NATRNatures Sunshine Pro...+0.05+0.40%
CDXCChromadex Corp0.000.00%
Data as of 4:14pm ET, 01/20/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$23.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Director, Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts


Search for Jobs